Diabetes treatment: NAFDAC approves CLUCOZIL produced by Emeka Emordi

0

A herbal drug, GLUCOZIL, manufactured by Emeka Emordi, of Ambrose Alli University in Edo state, has received approval of the National Agency for Food and Drug administration and Control (NAFDAC) for the treatment of diabetes mellitus.

NAFDAC’s approval of the drug for public use was announced in a statement by AAU’s Head of Corporate Communication in the Office of the Vice Chancellor, Otunba Mike Aladenika, which was made available to newsmen yesterday in Benin, the state capital.

“Its bid to reclaim its enviable position among the comity of institutions, grounded in research and higher learning, has received the approval of NAFDAC, as well as the rights of production and patents of GLUCOZIL,” he statement said.

Head of the Department of Pharmacology and Sub-Dean in Basic Clinical Sciences at the university’s College of Medicine, Dr. Jonathan Emeka Emordi, who produced the drug, said: “GLUCOZIL is a natural product that is prepared for the treatment of diabetes mellitus.

“GLUCOZIL as a natural product manufactured to cause a regeneration of the better cells that have been destroyed.

“If the product is used for a very long period, it will not only manage diabetes but cure it completely.”

According to him, GLUCOZIL, which can be used for the management, treatment and cure of diabetes, has bonus clinical indications for the treatment of BPH, commonly called enlarged prostate.

“In my analysis of the product, it was discovered that it has the capacity to shrink the prostate so that surgical operations can be avoided.

“The product is scientifically tested, right dose confirmed, safety proven in both humans and animals.

“It is also capable of flushing the human system. Simply put, it is a detoxifier. It has strong anti-oxidant and anti-inflammatory activities which makes it an immune booster,” he said.

Praising Emordi, AAU’s acting Vice Chancellor Prof. Sonnie Adagbonyin, said the management was happy with the feat achieved at the College of Medicine and the Department of Pharmacology.

“We are proud of the ranking of our scholars who are determined to excel and do us proud, despite the various human and environmental challenges.

“Management is proud of Dr. Emordi, and I enjoin other scholars to see his achievement as motivation for them to break new grounds, open new frontiers of knowledge and innovation.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here